The Study Of Effect Of Enhanced Recovery After Surgery On Postoperative Rehabilitation For Pediatric Hirschsprung’s Disease

Objective:To explore the influence of enhanced recovery after surgery in the postoperative rehabilitation of children with Hirschsprung’s disease through the application of enhanced recovery after surgery in the perioperative period of Pediatric Hirschsprung disease.Methods:Retrospective analysis was performed on the clinical data of 85 children diagnosed with HD in the Pediatric General Thoracic Surgery Department of the Affiliated Hospital of Zunyi Medical University between January 2015 and December 2020.Among them,from January 2015 to December 2017 Thirty-five cases were treated as a control group according to traditional perioperative management.From January 2018 to December2020,50 children were managed in the ERAS mode as the ERAS group.Compare the postoperative gastrointestinal function recovery of the two groups of children,preoperative and postoperative day 1,4,white blood cells(WBC),neutrophils(NEUT),hemoglobin(HB),total protein(TP),albumin(ALB),Prealbumin(PA),postoperative hospital stay,hospitalization costs,and postoperative complications.Results:Postoperative gastrointestinal function recovery:ERAS group was significantly shorter than the control group(2.56±0.36vs4.66±0.49)d,compared between the two groups,P<0.05,the difference was statistically significant.Postoperative hospital stay:ERAS group was significantly shorter In the control group(10.44±0.45vs16.54±0.42)d,compared between the two groups,P<0.05,the difference was statistically significant.The cost of hospitalization:the ERAS group was significantly lower than the control group(39791.71±462.13vs45880.46±587.54)Yuan,comparison between the two groups,P<0.05,the difference is statistically significant.There was no significant difference in WBC、NEUT、HB、TP、ALB、PA between the two groups of children before surgery,P>0.05,no statistical significance;WBC on the 1st day and 4th day after surgery:(11.46±1.25vs12.00±1.36)×10~9and(7.95±0.94vs8.88±0.91)×10~9,NEUT on the 1st day and 4th day after surgery:(0.66±0.03vs0.70±0.05)%and(0.49±0.05vs0.56±0.05)%,the ERAS group was lower than the control group.Comparison between the two groups,P<0.05,the difference was statistically significant.;HB on the 1st day and the 4th day after surgery:(100.56±22.54vs101.26±22.36)g/L and(105.88±20.35vs106.62±20.2)g/L,Comparison of the two groups,P>0.05,the difference was not statistically significant;TP on the 1st day and the 4th day after surgery:(49.34±8.21vs46.73±8.15)g/L and(58.88±10.11vs55.32±10.25),ALB on the 1st day and the 4th day after surgery:(32.75±5.21vs30.85±5.18)g/L and(40.77±5.15vs37.84±5.23)g/L,PA on the 1st day and the4thdayaftersurgery:(118.78±21.25vs113.97±21.36)g/Land(142.88±20.36vs124.54±20.18),The ERAS group was higher than the control group.Comparison between the two groups,P<0.05,The difference was statistically significant.postoperative complications:postoperative complication rate:ERAS group 12%,control group 34.29%,both groups Comparison,P<0.05,the difference is statistically significant.Conclusion:The application of ERAS in perioperative period for Pediatric Hirschsprung’s disease is safe and effective.It can significantly shorten the recovery time of postoperative gastrointestinal function,postoperative hospital stay,reduce hospitalization expens-es and stress reaction of children,and reduce the incidence of postoperative compli-cations.It has good clinical application value and is worthy of popularization and application.